John M. Yanni

1.9k total citations
52 papers, 1.6k citations indexed

About

John M. Yanni is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Immunology and Allergy. According to data from OpenAlex, John M. Yanni has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 19 papers in Immunology and 12 papers in Immunology and Allergy. Recurrent topics in John M. Yanni's work include Ocular Surface and Contact Lens (23 papers), Mast cells and histamine (17 papers) and Allergic Rhinitis and Sensitization (12 papers). John M. Yanni is often cited by papers focused on Ocular Surface and Contact Lens (23 papers), Mast cells and histamine (17 papers) and Allergic Rhinitis and Sensitization (12 papers). John M. Yanni collaborates with scholars based in United States and China. John M. Yanni's co-authors include Daniel A. Gamache, Joan M. Spellman, Gustav Graff, Lori K. Weimer, Najam A. Sharif, Steven T. Miller, Milton T. Brady, Shouxi Xu, Naj Sharif and Loretta G. McNatt and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

John M. Yanni

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
John M. Yanni United States 23 729 501 497 395 246 52 1.6k
Katrina J. Binger Australia 21 51 0.1× 19 0.0× 245 0.5× 78 0.2× 551 2.2× 35 1.2k
Hiroshi Kosano Japan 16 34 0.0× 17 0.0× 82 0.2× 206 0.5× 551 2.2× 46 1.0k
Esther Carrasco Spain 19 31 0.0× 19 0.0× 163 0.3× 695 1.8× 571 2.3× 33 1.5k
Mei Zhang China 17 34 0.0× 24 0.0× 140 0.3× 18 0.0× 334 1.4× 54 842
Delu Che China 19 17 0.0× 332 0.7× 597 1.2× 5 0.0× 325 1.3× 73 1.0k
Dagmar Hahn Switzerland 20 32 0.0× 129 0.3× 53 0.1× 25 0.1× 469 1.9× 38 1.2k
Kwang Won Jeong South Korea 20 36 0.0× 12 0.0× 129 0.3× 128 0.3× 1.4k 5.7× 49 1.8k
Michitaka Shichijo Japan 20 26 0.0× 340 0.7× 738 1.5× 2 0.0× 361 1.5× 40 1.5k
Tetsuro Yoshimaru Japan 23 16 0.0× 215 0.4× 659 1.3× 5 0.0× 702 2.9× 50 1.5k
Marie Paule Defresne Belgium 14 24 0.0× 33 0.1× 170 0.3× 49 0.1× 314 1.3× 32 689

Countries citing papers authored by John M. Yanni

Since Specialization
Citations

This map shows the geographic impact of John M. Yanni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John M. Yanni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John M. Yanni more than expected).

Fields of papers citing papers by John M. Yanni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John M. Yanni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John M. Yanni. The network helps show where John M. Yanni may publish in the future.

Co-authorship network of co-authors of John M. Yanni

This figure shows the co-authorship network connecting the top 25 collaborators of John M. Yanni. A scholar is included among the top collaborators of John M. Yanni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John M. Yanni. John M. Yanni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Beauregard, Clay, et al.. (2007). Duration of Action of Topical Antiallergy Drugs in a Guinea Pig Model of Histamine-Induced Conjunctival Vascular Permeability. Journal of Ocular Pharmacology and Therapeutics. 23(4). 315–320. 4 indexed citations
2.
Gamache, Daniel A., et al.. (2005). Preservation of Tear Film Integrity and Inhibition of Corneal Injury by Dexamethasone in a Rabbit Model of Lacrimal Gland Inflammation–Induced Dry Eye. Journal of Ocular Pharmacology and Therapeutics. 21(2). 139–148. 49 indexed citations
3.
Gamache, Daniel A., et al.. (2004). Rimexolone dose–dependently inhibits corneal staining and increases tear breakup time in a rabbit model of lacrimal gland inflammation–induced dry eye. Investigative Ophthalmology & Visual Science. 45(13). 62–62. 1 indexed citations
4.
Bhattacherjee, P., Partha Mukhopadhyay, Christopher A. Paterson, et al.. (2003). AL-2512, a Novel Corticosteroid: Preclinical Assessment of Anti-Inflammatory and Ocular Hypertensive Effects. Journal of Ocular Pharmacology and Therapeutics. 19(4). 353–360. 5 indexed citations
5.
Brockman, Howard L., et al.. (2003). Interactions of olopatadine and selected antihistamines with model and natural membranes. Ocular Immunology and Inflammation. 11(4). 247–268. 52 indexed citations
6.
Kapin, Michael A., John M. Yanni, Milton T. Brady, et al.. (2003). Inflammation-Mediated Retinal Edema in the Rabbit Is Inhibited by Topical Nepafenac. Inflammation. 27(5). 281–291. 61 indexed citations
7.
Gamache, Daniel A., et al.. (2002). Preservation of Corneal Integrity by the Mucin Secretagogue 15(S)-HETE in a Rabbit Model of Desiccation-Induced Dry Eye. Advances in experimental medicine and biology. 506(Pt A). 335–340. 16 indexed citations
8.
Gamache, Daniel A., et al.. (2002). Corneal Protection by the Ocular Mucin Secretagogue 15(S)-HETE in a Rabbit Model of Desiccation-induced Corneal Defect. Journal of Ocular Pharmacology and Therapeutics. 18(4). 349–361. 26 indexed citations
9.
Gamache, Daniel A., Gustav Graff, Milton T. Brady, Joan M. Spellman, & John M. Yanni. (2000). Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: I. Assessment of Anti-Inflammatory Efficacy. Inflammation. 24(4). 357–370. 114 indexed citations
10.
McNatt, Loretta G., Lori K. Weimer, John M. Yanni, & Abbot F. Clark. (1999). Angiostatic Activity of Steroids in the Chick Embryo CAM and Rabbit Cornea Models of Neovascularization. Journal of Ocular Pharmacology and Therapeutics. 15(5). 413–423. 61 indexed citations
11.
Gamache, Daniel A., S. Dan Dimitrijevich, Lori K. Weimer, et al.. (1997). Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Ocular Immunology and Inflammation. 5(2). 117–128. 84 indexed citations
12.
Yanni, John M., Steven T. Miller, Lori K. Weimer, et al.. (1996). The In Vitro and In Vivo Ocular Pharmacology of Olopatadine (AL-4943A), an Effective Anti-Allergic/Antihistaminic Agent. Journal of Ocular Pharmacology and Therapeutics. 12(4). 389–400. 96 indexed citations
13.
Sharif, Najam A., Shouxi Xu, & John M. Yanni. (1996). Olopatadine (AL-4943A): Ligand Binding and Functional Studies on a Novel, Long Acting H1-Selective Histamine Antagonist and Anti-Allergic Agent for Use in Allergic Conjunctivitis. Journal of Ocular Pharmacology and Therapeutics. 12(4). 401–407. 61 indexed citations
14.
Miller, Steven T., Ellen B. Cook, Frank M. Graziano, Joan M. Spellman, & John M. Yanni. (1996). Human conjunctival mast cell responses in vitro to various secretagogues. Ocular Immunology and Inflammation. 4(1). 39–50. 27 indexed citations
15.
Sharif, Naj, et al.. (1994). Emedastine: A Potent, High Affinity Histamine H 1 -Receptor-Selective Antagonist for Ocular Use: Receptor Binding and Second Messenger Studies. Journal of Ocular Pharmacology and Therapeutics. 10(4). 653–664. 51 indexed citations
16.
Yanni, John M., et al.. (1994). Preclinical Efficacy of Emedastine, a Potent, Selective Histamine H 1 Antagonist for Topical Ocular Use. Journal of Ocular Pharmacology and Therapeutics. 10(4). 665–675. 38 indexed citations
17.
Walsh, David A., et al.. (1990). The synthesis and antiallergy activity of 1-(aryloxy)-4-(4-arylpiperazinyl)-2-butanol derivatives. Journal of Medicinal Chemistry. 33(6). 1823–1827. 9 indexed citations
18.
Walsh, D., et al.. (1989). Synthesis and antiallergy activity of 4-(diarylhydroxymethyl)-1-[3-(aryloxy)propyl)piperidines and structurally related compounds. Journal of Medicinal Chemistry. 32(1). 105–118. 23 indexed citations
19.
Yanni, John M., et al.. (1989). Effect of Intravenously Administered Lipoxygenase Metabolites on Rat Tracheal Mucous Gel Layer Thickness. International Archives of Allergy and Immunology. 90(3). 307–309. 15 indexed citations
20.
Yanni, John M., et al.. (1988). U46619 and carbocyclic thromboxane A2-induced increases in tracheal mucous gel layer thickness. Prostaglandins Leukotrienes and Essential Fatty Acids. 32(1). 45–49. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katrina J. Binger Breakdown of academic impact, for papers by Hiroshi Kosano Breakdown of academic impact, for papers by Esther Carrasco Breakdown of academic impact, for papers by Mei Zhang Breakdown of academic impact, for papers by Delu Che Breakdown of academic impact, for papers by Dagmar Hahn Breakdown of academic impact, for papers by Kwang Won Jeong Breakdown of academic impact, for papers by Michitaka Shichijo Breakdown of academic impact, for papers by Tetsuro Yoshimaru Breakdown of academic impact, for papers by Marie Paule Defresne
Rankless by CCL
2026